
FILE PHOTO: A pharmacy tech poses for a picture with hydrocodone bitartrate and acetaminophen tablets, the generic version of Vicodin in Edmond, Okla.
Sue Ogrocki / The Associated Press
FILE PHOTO: A pharmacy tech poses for a picture with hydrocodone bitartrate and acetaminophen tablets, the generic version of Vicodin in Edmond, Okla.
Sue Ogrocki / The Associated Press
This proposal threatens to cut federal funding for public media, putting at risk the emergency communications, trusted news and educational programming that our community depends on. Now is the time to act. Call your lawmakers and donate today to help protect the future of local public media.
Sue Ogrocki / The Associated Press
FILE PHOTO: A pharmacy tech poses for a picture with hydrocodone bitartrate and acetaminophen tablets, the generic version of Vicodin in Edmond, Okla.
(Harrisburg) — Pennsylvania is in line to receive more than $53 million as part of a nationwide settlement with a British company that once distributed a drug used to treat opioid addiction.
Pennsylvania Attorney General Josh Shapiro said Thursday that the money is to settle allegations that the company defrauded Medicaid and other state health care programs.
The U.S. Department of Justice had accused an ex-Reckitt Benckiser subsidiary of marketing Suboxone Film by saying the drug was safer than other opioid addiction treatments.
Reckitt Benckiser said in July that it would pay $1.4 billion to resolve federal investigations. The states’ share of the settlement is $700 million.
Suboxone Film was marketed by RB’s former prescription business Indivior, which was spun off in 2014.
Reckitt Benckiser has denied any wrongdoing.
Sometimes, your mornings are just too busy to catch the news beyond a headline or two. Don’t worry. The Morning Agenda has got your back. Each weekday morning, The Morning Agenda will keep you informed, amused, enlightened and up-to-date on what’s happening in central Pennsylvania and the rest of this great commonwealth.